UK Cannabis Policy Is Failing Children – A Regulated Market Is Needed

A new report by VolteFace highlights the impact that cannabis policy is having on young people. The report’s focus is mainly on high strength THC cannabis that is purchased on the street and consumed by people who would be under the legal age if there were to be a legal cannabis market in the UK similar to that of Canada and a growing number of US states. The Children’s Inquiry report aims to highlight the increase in harm that current drug policy is having on young people and looks at…

Read More

Progress in Malta

For months, a crucial step forward in progressive medicine in yet another European country has, on the whole, gone under the radar. Earlier this year on 9th March, the Maltese government amended its Drug Dependence Act to fully legalise the medical use of cannabis. The amendment, listed on Pain Clinic’s website, states that, “a licenced medical practitioner who is duly registered in accordance with the Health Care Professions Act, shall be entitled to prescribe to patients medicinal preparations of the plant cannabis and synthetic Cannabinoid products… if it is considered…

Read More

Comment: Police do not give cannabis users tacit approval

By Edouard-Henri Desforges, UK Cannabis Social Clubs Deputy Vice Chairman The police have been accused by Conservatives of giving ‘tacit approval’ to collectives like the UKCSC. Our modern constabulary are mostly involved in ‘responsive policing’ – maybe cannabis users simply do not merit citizens reporting the crime? Possession of medical cannabis is a victimless crime anyway! There is hardly tacit approval, given the police arrest people and stay silent on the subject usually until they are ex-coppers, and then say they don’t have the resources to police something that is…

Read More

UK Medicinal Cannabis: Still A Long Way To Go

Recommendations by a rushed ‘review of reviews’ by Dame Sally Davies, the Chief Medical Officer for England, regarding medicinal cannabis are being implemented by the Home Office, meaning certain ‘cannabis-derived’ medications will be reclassified and doctors will be permitted to prescribe them. Stuart Harper looks at the limits imposed by this small progressive move. The purpose of Davies’s review was to look at the scheduling of cannabis within the UK, cannabis currently being a schedule 1 substance, with the aim of downgrading its classification if the evidence supported such a…

Read More

UKCSC comment on ACMD Advice on Scheduling Cannabis Derived Medicinal Products

The UKCSC has released the following comments on new recommendations made by the Advisory Council on the Misuse of Drugs, which has told the government that doctors in the UK should have the option to prescribe cannabis-derived medicinal products to patients with certain medical conditions: While herbal cannabis seems to be covered by this new suggested rescheduling, it appears that it would have to be grown in a licensed facility, and not in a way where a patient is able to grow for their own personal care. Patients need the…

Read More